Precision medicine is imprecise when it comes to racial and ethnic minorities. Because these communities are underrepresented in most clinical trials and genetic studies, we’re missing opportunities to identify risk factors and develop effective treatments. By boosting inclusion, we are speeding our mission to find cures for all cancers in all people.
People from racial and ethnic minorities have higher rates of cancer and are more likely to die from the disease, while those who survive carry a heavier burden of negative health and economic impacts. To reduce these tremendous personal and economic costs, Fred Hutch researchers are using science to understand the factors that contribute to disparities and developing strategies to close the gaps.
Educating the next generation of researchers is mission-critical. We have developed inclusive and culturally relevant programs that attract students who are the first in their families to attend college, people with disabilities, veterans and those who belong to underrepresented racial or ethnic groups. By investing in education at Fred Hutch, you stoke dreams, strengthen science and lay the groundwork for future breakthroughs in cancer, HIV and other diseases.
Studies show that a lack of diversity among researchers contributes to cancer health disparities. Conversely, a diversity of experiences and perspectives unlocks wider-reaching and more innovative science. To ensure we’re doing the best research possible, and to better reflect the communities we serve, we are proactively building a more diverse workforce. Your support will help us become the employer of choice for people with new viewpoints and ideas who will help us achieve our mission faster.
— Dr. Thomas J. Lynch Jr., Fred Hutch president and director and holder of the Raisbeck Endowed Chair